| Application no. and date | 02779063.3 (espacenet) (Federated) (European Patent Register), 20021118 | | Patent/reg. no. and date | DK/EP 1442058, 20060719 | | Publication date | 20040804 | | Priority no. and date | US 331477 P, 20011116 | | EP pub. no. and date |
EP 1442058 20040804 | | Effective date | | | Applicant/owner | NYMOX CORPORATION, 9600 Cavendish Blvd.Suite 306
St. LaurentQuebec H4M 2V2, CA | | Applicant ref. no. | P36775DK01 | | Inventor | AVERBACK, Paul, 383 Lakeshore Road
Beaconsfield, Québec H9W 4J1, CA,
GEMMELL, Jack, 1330 Queen Victoria Avenue
Mississauga, Ontario L5H 3H3, CA | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , C07K 14/47 (2006.01) | | Title | Peptider der er effektive til behandling af tumorer og andre tilstande der kræver fjernelse eller destruktion af celler | | Int. application no. | CA2002001757 | | Int. publication no. | WO2003044053 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
